Migraine is a major neurological disorder affecting one in nine adults worldwide with a significant impact on health care and socioeconomic systems. Migraine is more prevalent in women than in men, with 17% of all women meeting the diagnostic criteria for migraine. In women, the frequency of migraine attacks shows variations over the menstrual cycle and pregnancy, and the use of combined hormonal contraception (CHC) or hormone replacement therapy (HRT) can unveil or modify migraine disease. In the general population, 18–25% of female migraineurs display a menstrual association of their headache. Here we present an overview on the evidence supporting the role of reproductive hormones, in particular estrogens, in the pathophysiology of migraine. We also analyze the efficacy and safety of prescribing exogenous estrogens as a potential treatment for menstrual-related migraine. Finally, we point to controversial issues and future research areas in the field of reproductive hormones and migraine.

PubMed Central - PMC - Open Access Resources for WCM Alumni and Retirees - LibGuides at Weill Cornell Medical College

Introduction to Cells with Informational Texts, Label a Cell, and Organizers

Cells Free Full-Text Need For NAD Focus On Striated Muscle , 55% OFF

Nucleic acid biomarkers of immune response and cell and tissue damage in children with COVID-19 and MIS-C - ScienceDirect

Best Free Animal Cell Worksheets: With Answers & Easy Print! - The Simple Homeschooler

Cells Free Full-Text Can We Use Ginkgo Biloba Extract To, 59% OFF

Nanopore Sequencing of Cell-Free DNA as a Biomarker for ALL

/wp-content/uploads/2020/09/oxidative

Cells, Free Full-Text, spider silk tibia

Cells, Free Full-Text